Product

ACT-132577

Aliases

Aprocitentan

Name

TRYVIO

INN Name

Aprocitentan

FDA Approved

Yes

2 clinical trials

1 organization

2 indications

1 document

Indication

Healthy Subjects

Indication

Chronic Kidney Disease

Clinical trial

Single-center, Open-label Study With 14C-radiolabeled ACT-132577 to Investigate the Mass Balance, Pharmacokinetics, and Metabolism Following Single Oral Administration to Healthy Male Subjects

Status: Completed, Estimated PCD: 2017-04-18

Clinical trial

A Single-center, Open Label, Single-dose Study to Investigate the Effect of Severe Renal Impairment on the Pharmacokinetics of ACT-132577

Status: Completed, Estimated PCD: 2017-10-27

Document

DailyMed Label: TRYVIO

Organization

Idorsia Pharmaceuticals Ltd